Announcement on Obtaining Drug Registration Certificate for Compound Sodium Acetate Ringer's Injection
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Obtaining Drug Registration Certificate for Compound Sodium Acetate Ringer's Injection
Filed with SSE · · 2 pages · Chinese
Release
Zhejiang Medicine Co., Ltd. on 6ix
Earlier from Zhejiang Medicine
- Announcement on the Subsidiary Zhejiang Novus Pharmaceuticals Co., Ltd. Passing On-site Inspection by FDA
- Announcement on Expected Increase in Annual Performance for 2024
- Announcement on Completion of Industrial and Commercial Registration for Changes in Equity Structure of Controlling Shareholder and Change of Actual Controller
- Announcement on "Corporate Value and Return Enhancement" Action Plan
- Indicative Announcement on Changes in Equity Structure of Controlling Shareholder and Actual Controller
Later from Zhejiang Medicine
- Announcement on the Shareholding Reduction Plan for Shareholders Holding More than 5% of Shares through Call Auction
- Indicative Announcement on Proposal of Chairman to Repurchase Shares
- Announcement on Plan for Repurchasing Shares through Call Auction
- Announcement on Obtaining Commitment Letter for Share Repurchase Loans from Financial Institutions
- Announcement on Resolution of the 5th Meeting of the 10th Board of Directors
Follow Zhejiang Medicine into a list and get an email when it puts out news.
Follow Zhejiang Medicine